NUS1 and Parkinson disease: In addition, PD patients carrying the NUS1 c.691 + 3dupA variant show significantly decreased mRNA expression, but no studies have investigated the changes in NgBR levels in either plasma or cerebrospinal fluid (CSF) [6].